The exploratory observational study on the safety of Dormolol combination ophthalmic solution wakamoto under medical practice.

The exploratory observational study on the safety of Dormolol combination ophthalmic solution wakamoto under medical practice. - The observational study on the safety of Dormolol combination ophthalmic solution wakamoto.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040623

Enrollment

100

Registered

2020-06-03

Start date

2020-06-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma Ocular hypertension

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Not applicable

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

Measure	Time frame
Side effects: types, incidence rates	—

Secondary

Measure	Time frame
Intraocular pressure(IOP): IOP value, Mean IOP reduction from baseline at all measurement points, percentage change from baseline	—

Countries

Japan

Contacts

Public ContactSeiji Kurosawa

Wakamoto Pharmaceutical Co., Ltd. Medical Affairs Department

cli-trial@wakamoto-pharm.co.jp03-3279-0958

Outcome results